Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
Chaturvedi
Nish
N
Bilous
Rudy
R
Sjolie
Anne Katrin
AK
Klein
Ron
R
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012171:Retinal Vessels / Q000473:pathology
D000959:Antihypertensive Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents